Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988414 · ClinicalTrials.gov registry record
Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
A clinical trial, sponsored by Karius.
- Completed
- Registry status
- 108
- Enrollment target
NCT02988414 is a clinical trial that has completed, run by Karius. The registered enrollment target is 108 participants.
The verdict
NCT02988414 has completed, sponsored by Karius.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
Prospective study at Duke University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to blood culture results in admitted patients with bacteremia/septicemia.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02988414
The ClinicalTrials.gov registry entry for NCT02988414 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karius, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02988414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02988414 about?
NCT02988414 is a clinical study titled "Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay". Prospective study at Duke University Hospital comparing the Karius Infectious Disease Diagnostic Sequencing Assay to blood culture results in admitted patients with bacteremia/septicemia.
What is the current status of trial NCT02988414?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2016-07. Estimated completion is 2017-04.
Who is sponsoring clinical trial NCT02988414?
This trial is sponsored by Karius, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.